Bruton Tyrosine Kinase BTK Inhibitor Market Growth: Key Drivers
  The growth of the Bruton Tyrosine Kinase BTK inhibitor market is fueled by increasing prevalence of hematologic cancers and autoimmune diseases. BTK inhibitors are a cornerstone in targeted therapy, providing effective treatment while reducing systemic side effects. Next-generation BTK inhibitors offer improved safety profiles, enhancing patient adherence. Pharmaceutical companies are...
0 Comments 0 Shares 333 Views 0 Reviews